dc.contributor.author
Böhmer, Dirk
dc.contributor.author
Grün, Arne
dc.date.accessioned
2023-06-20T12:22:17Z
dc.date.available
2023-06-20T12:22:17Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/39854
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-39575
dc.description.abstract
We comment on the paper of Di Maria Jiang et al. published in Current Oncology Reports 2020, https://doi.org/10.1007/s11912020-0880-5. We disagree on a major recommendation of the authors because of lacking evidence. This response is considered to be important for readers of Current Oncology Reports.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Bladder cancer
en
dc.subject
Trimodality treatment
en
dc.subject
Neoadjuvant chemotherapy
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer
dc.type
Letter to the Editor
dc.title.subtitle
In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5
dcterms.bibliographicCitation.articlenumber
18
dcterms.bibliographicCitation.doi
10.1007/s11912-020-01012-8
dcterms.bibliographicCitation.journaltitle
Current Oncology Reports
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
23
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
33471212
dcterms.isPartOf.issn
1523-3790
dcterms.isPartOf.eissn
1534-6269
